BSSI News & Events


We will be speaking and/or attending the conferences below. Please contact us if you would like to meet with us.


February 20, 2018: BSSI is proud to support 3D Signatures in their development of the Telo-HL™ test for Hodgkin’s Lymphoma.

December 14, 2017: BioStat Solutions, Inc. announced today that Eloi Kpamegan, Ph.D. has joined as Director of Clinical Operations.

BSSI is supporting 3D Signatures Inc.’s Hodgkin’s Lymphoma Test Validation Program by developing a scoring model to distinguish patients with non-aggressive disease from patients with aggressive disease that may relapse within 12 months of treatment with standard first-line chemotherapy.

We are hiring! We are looking for Statistical Geneticists, Statisticians, Lead Statisticians, Clinical Statistical Analysts and Statistical Analysts. Please send us your resume to join our talented team!